Top Biotechnology companies in Denmark by Receivables

This ranking features the top 11 Biotechnology companies in Denmark ranked by Receivables, totalling a Receivables of USD 1.66 B, for January 15, 2025.
#
Name
Receivables
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 732.25 M
Dec. 31, 2023 USD 216.88 1.28%

Denmark

2
USD 558.33 M
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

3
USD 263.19 M
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

4
USD 61.56 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

5
USD 18.11 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

6
USD 12.01 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

7
USD 8.96 M
June 30, 2024 USD 70.50 0.61%

Denmark

8
USD 489.35 K
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

9
USD 249.32 K
Dec. 31, 2023 USD 0.57 1.47%

Denmark

10
USD 0.00
Dec. 31, 2023 USD 5.46 0.56%

Denmark

11
USD 0.00
Dec. 31, 2023 USD 2.17 5.88%

Denmark

Frequently Asked Questions
  • Which Biotechnology company in Denmark has the highest Receivables ?

    The Biotechnology company in Denmark with the highest Receivables is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 732.25 M.

  • Which Biotechnology company in Denmark has the lowest Receivables ?

    The Biotechnology company in Denmark with the lowest Receivables is ExpreS2ion Biotech Holding AB (publ) (Stockholm Stock Exchange: EXPRS2.ST) at USD 0.00.